CDK4 and mantle cell lymphoma: Co-treatment with ARV-771 and venetoclax (BCL2 inhibitor), ibrutinib (BTK inhibitor), or palbociclib (CDK4/6 inhibitor) synergistically induced apoptosis in MCL cells [73].